In previous studies, overexpression of Lasp1 was identified as a prognostic factor of patients’ adverse survival in a number of cancer entities, including breast cancer, colorectal cancer, gastric cancer, hepatocellular cancer, lung cancer, etc [11, 15, 23, 27, 30–33]. This evidence concerns the gene LASP1 and breast carcinoma.